US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 7, 2025 (1 years ago)

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Super-Potent Drug: Out of specification potency results were obtained.

What was recalled

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

Recalling firm
Mylan Institutional, Inc.
NDC code
51079-445-20
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0290-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Levothyroxine recalls

See all